Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Solid Biosciences Inc.
SLDB
Other Research And Development Expense
Other Research And Development Expense at other companies
Celanese Corporation
CE
$0
—
Corvex
MOVE
$899K
+12.4%
Disc Medicine
IRON
$2.17M
+18.2%
TG Therapeutics
TGTX
$43.52M
+1.1%
Shattuck Labs, Inc.
STTK
$1.9M
+46.2%
Dianthus Therapeutics
DNTH
$1.49M
+25.5%
Segments
By product
See full
External Research And Development Other
$2.86M
+3.1%
Other financials
Income statement
See full
Revenue
$2.0M
-40.6%
Operating income
-$57.3M
-43.1%
Net income
-$56.7M
-44.4%
EPS (diluted)
-$0.52
+11.9%
Balance sheet
See full
Cash & equivalents
$297.1M
+41.1%
Total debt
$20.7M
-12.5%
Total equity
$374.1M
+27.1%
Total assets
$422.9M
+23.0%
Cash flow
See full
Operating cash flow
-$47.2M
-48.3%
CapEx
$165.0K
+31.0%
Free cash flow
-$47.4M
-48.2%
Valuation
See full
Market cap
$872.26M
+135%
Enterprise value
$595.83M
+223%
P/S
107.8×
-9.9×
Profitability
See full
Operating margin
-1,315.2%
-4,060pp
Net margin
-1,062.3%
-251,151pp
FCF margin
-1,247.7%
-9,569pp
Returns & leverage
See full
Return on equity
-57.4%
+2.2pp
Debt / equity
0.1×
0.0×
Current ratio
13.1×
+2.2×